Hospitals, doctors delaying price transparency law in Ohio

Ohio passed a law requiring “good faith” estimates from providers to patients on the cost of elective procedures two years ago, but opposition from the state’s hospital and physician groups has keep the law from being implemented.

As Kaiser Health News reports, groups like the Ohio Hospital Association have successfully stalled the law with a court injunction, arguing coming up with estimates would delay patient care. The law’s sponsor, Ohio State Rep. Jim Butler, says their real motivation has nothing to with concerns about patients.

“The health care industry has a lot of political power and lots of money. It’s hard to fight on behalf of people against this kind of force,” he said.

Read the full article at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.